Gordian Biotechnology
Nino Solano has a diverse work experience spanning different industries. In 2011, Nino started as a Sales Associate at Toys R Us, where they quickly excelled and became the top earner of donations. They continued working there until 2012 when they joined BevMo! as a Head Clerk. In this role, they successfully managed a team, ensured customer satisfaction, and handled opening and closing duties.
In 2017, Nino transitioned to MBC Biolabs and took on the position of Facilities Engineer. They demonstrated their skills in managing projects and leading teams, earning the role of Team Lead & Project Manager in 2018. Nino held both roles until 2022.
Currently, Nino works at Gordian Biotechnology as an Associate Facilities Manager, starting in June 2022.
Nino Solano's education history begins in 2008 when they attended Skyline College. During their time at Skyline College, Nino obtained an Associate of Arts (A.A.) degree in Multi/Interdisciplinary Studies, an Associate of Science (A.S.) degree in Business Administration and Management, General, and another Associate of Arts (A.A.) degree in Psychology. They attended Skyline College from 2008 to 2012.
Following their time at Skyline College, Nino Solano then went on to attend San Francisco State University from 2012 to 2014. At San Francisco State University, Nino obtained a Bachelor of Arts (B.A.) degree in Psychology.
In addition to their formal education, Nino Solano also obtained several certifications. In October 2019, they received Job Instruction Training from Lean Frontiers, Inc. and Training Within Industry from the TWI Institute Headquarters.
Furthermore, in January 2020, Nino received certifications in Blood Borne Pathogens and Injury & Illness Prevention from Ingenium. Lastly, in January 2023, Nino obtained OSHA 40-Hour HAZWOPER Training from the South Florida College of Public Health.
This person is not in the org chart
This person is not in any teams
Gordian Biotechnology
Gordian is a therapeutics company pioneering a novel screening platform to radically increase the efficiency of development for complex diseases of aging.